Cross-immunizing potential of tumor MAGE-A epitopes recognized by HLA-A*02:01-restricted cytotoxic T lymphocytes
![]() |
Huang, Ze-Min
(Department of Immunology, Third Military Medical University)
Jia, Zheng-Cai (Biomedical Analysis Center, Third Military Medical University) Tang, Jun (Department of Dermatology, the 105th Hospital of PLA) Zhang, Yi (Department of Immunology, Third Military Medical University) Tian, Yi (Department of Immunology, Third Military Medical University) Ni, Dong-Jing (Department of Immunology, Third Military Medical University) Wang, Fang (Biomedical Analysis Center, Third Military Medical University) Wu, Yu-Zhang (Department of Immunology, Third Military Medical University) Ni, Bing (Department of Immunology, Third Military Medical University) |
1 | Valmori, D., Lienard, D., Waanders, G., Rimoldi, D., Cerottini, J. C. and Romero, P. (1997) Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients. Cancer Res. 57, 735-741. |
2 | Valmori, D., Gileadi, U., Servis, C., Dunbar, P. R., Cerottini, J. C., Romero, P., Cerundolo, V. and Levy, F. (1999) Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3. J. Exp. Med. 189, 895-906. DOI |
3 | Guillaume, B., Chapiro, J., Stroobant, V., Colau, D., Van Holle, B., Parvizi, G., Bousquet-Dubouch, M. P., Theate, I., Parmentier, N. and Van den Eynde, B. J. (2010) Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules. Proc. Natl. Acad. Sci. U.S.A. 107, 18599-18604. DOI ScienceOn |
4 | Nijman, H. W., Houbiers, J. G., Vierboom, M. P., van der Burg, S. H., Drijfhout, J. W., D'Amaro, J., Kenemans, P., Melief, C. J. and Kast, W. M. (1993) Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. Eur. J. Immunol. 23, 1215-1219. DOI ScienceOn |
5 | Guttridge, M. G., Street, J., Thomas, M. and Darke, C. (1999) Identification of HLA-A*0224: implications for PCR-SSP HLA typing. Tissue Antigens 53, 190-193. DOI ScienceOn |
6 | Tang, Y., Lin, Z., Ni, B., Wei, J., Han, J., Wang, H. and Wu, Y. (2007) An altered peptide ligand for naive cytotoxic T lymphocyte epitope of TRP-2(180-188) enhanced immunogenicity. Cancer Immunol. Immunother. 56, 319-329. |
7 | Shinohara, M. L., Jansson, M., Hwang, E. S., Werneck, M. B., Glimcher, L. H. and Cantor, H. (2005) T-bet-dependent expression of osteopontin contributes to T cell polarization. Proc. Natl. Acad. Sci. U.S.A. 102, 17101-17106. DOI ScienceOn |
8 | Serrano, A., Lethe, B., Delroisse, J. M., Lurquin, C., De Plaen, E., Brasseur, F., Rimoldi, D. and Boon, T. (1999) Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries. Int. J. Cancer 83, 664-669. DOI |
9 | Otte, M., Zafrakas, M., Riethdorf, L., Pichlmeier, U., Loning, T., Janicke, F. and Pantel, K. (2001) MAGE-A gene expression pattern in primary breast cancer. Cancer Res. 61, 6682-6687. |
10 | Jia, Z. C., Tian, Y., Huang, Z. M., Wang, J. X., Fu, X. L., Ni, B. and Wu, Y. Z. (2011) Identification of a new MAGE-A10 antigenic peptide presented by HLA-A*0201 on tumor cells. Cancer Biol. Ther. 11, 395-400. DOI |
11 | Novellino, L., Castelli, C. and Parmiani, G. (2005) A listing of human tumor antigens recognized by T cells: March 2004 update. Cancer Immunol. Immunother. 54, 187-207. DOI |
12 | Jia, Z. C., Ni, B., Huang, Z. M., Tian, Y., Tang, J., Wang, J. X., Fu, X. L. and Wu, Y. Z. (2010) Identification of two novel HLA-A*0201-restricted CTL epitopes derived from MAGE-A4. Clin. Dev. Immunol. 2010, 567594. |
13 | van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Boel, P., De Smet, C., Traversari, C., Townsend, A. and Boon, T. (1994) A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol. 24, 3038-3043. DOI ScienceOn |
14 | Tourdot, S., Scardino, A., Saloustrou, E., Gross, D. A., Pascolo, S., Cordopatis, P., Lemonnier, F. A. and Kosmatopoulos, K. (2000) A general strategy to enhance immunogenicity of low-affinity HLA-A2. 1-associated peptides: implication in the identification of cryptic tumor epitopes. Eur. J. Immunol. 30, 3411-3421. DOI |
15 | Parker, K. C., Bednarek, M. A., Hull, L. K., Utz, U., Cunningham, B., Zweerink, H. J., Biddison, W. E. and Coligan, J. E. (1992) Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J. Immunol. 149, 3580-3587. |
16 | Jungbluth, A. A., Busam, K. J., Kolb, D., Iversen, K., Coplan, K., Chen, Y. T., Spagnoli, G. C. and Old, L. J. (2000) Expression of MAGE-antigens in normal tissues and cancer. Int. J. Cancer 85, 460-465. DOI |
17 | De Plaen, E., Arden, K., Traversari, C., Gaforio, J. J., Szikora, J. P., De Smet, C., Brasseur, F., van der Bruggen, P., Lethe, B., Lurquin, C., Brasseur, R., Chomez, P., De Backer, O., Cavenee, W. and Boon, T. (1994) Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40, 360-369. DOI ScienceOn |
![]() |